(PRWEB) September 26, 2011
Stem cell treatment centers are open on both US coasts. So to facilitate Midwest clients, Stem Cell WI, will be opening a clinic soon in Madison, WI by Jane Langdon. Jane has seen the remarkable results of stem cell treatment on her husband and sister-in-law who have Parkinsons Disease.
They will only use your own adult stem cells for treatment. These stem cells are not subject to any ethical or moral issues. Treatments are available for COPD/Lung Conditions, Diabetes, Lupus, Osteoarthritis, Parkinson’s Disease, Rheumatoid Arthritis, Stroke, Multiple Sclerosis and Joint Repair.
Stem cells are early stage cells that have the ability to continuously divide and develop into other specialized types of cells. For example, stem cells can turn into liver cells, skin cells, nerve cells, etc. Like a blank microchip that can ultimately be programmed to perform any one of a number of specialized tasks, stem cells are undifferentiated cells that do not yet have a specific physiological function. When proper conditions occur in the body or lab, stem cells begin to develop into specialized tissues and organs. These cells may have differing abilities to turn into more specialized cells and are self-sustaining, replicating through cell division.
Patients have their fat stem cells (usually abdominal) harvested in our special sterile treatment facility under a local anesthetic. The fat removal procedure lasts approximately twenty minutes. Specially designed equipment is used to harvest the fat cells and less than 100cc of fat is required. Your stem cells a reintroduced into your body after cleaning and a special low laser application. Post-operative discomfort is minimal and there is minimal restriction on activity. There is no concern for rejection since they are from your own body.
Costs range from $ 14,000 to $ 18,000. This is a small price when you consider what you are paying now for Doctors, hospital care, medications, restricted lifestyle and pain.
Question by van: I think I am getting arthritis…What is the first line of treatment when you go to the Dr.?
I am a 48 year old female.
Answer by belle
It depends: there are many different types of arthritis, like osteoarthritis or rheumatoid arthritis. If you see the doctor, they’ll ask you more questions to determine what kind you have. Your doctor might examine your joints to see how well they bend, and to look for swelling. Sometimes they order an xray. There is NO blood test to diagnose arthritis, so you probably won’t be stuck by a needle!!
For treatment, if you’re overweight, it might help to lose some weight. Your doctor can advise you which medications to take, depending on what type of arthritis you have. Good luck!
Add your own answer in the comments!
Worlds First Breakthrough Stem Cell Procedure on a Goat Performed in Kentucky Vet Clinic: Advanced Technology From MediVet-America Provides Animal Therapeutic Care
Nicholasville, KY (PRWEB) September 29, 2011
When Cinnamon, a seven-year-old, 325 pound goat, began receiving stem cell therapy on location at a veterinary clinic outside of Louisville, Kentucky, it was a medical first in the whole world for the animal kingdom.
The procedure at the Henry County Animal Clinic was performed by Dr. Clark Slone, DVM, to alleviate the pain Cinnamon suffered from a torn ACL and bad carpal joints.
Dr. Slone utilized the advanced, drug-free technology pioneered by MediVet-America (http://www.Medivet-America.com), a research and development company and global leader in veterinary stem cell technology and regenerative medicines.
Adult animal stem cell technology uses the bodys own regenerative healing power to help cure dogs, cats, horses and other animals suffering from arthritis, hip dysplasia and tendon, ligament and cartilage injuries and other ailments.
Fat tissue was removed from the animal, millions of stem cells were separated and activated on location through a patented L.E.D. technology, and then injected into the affected areas.
Within a month of the procedure, Cinnamon will be moving well, virtually pain free.
These stem cells are supercharged, theyre ready to work, and automatically go to the inflamed area in the body, said MediVet-Americas Brenda Timperman. The animals that were having problems recover and are a whole lot better.
Using MediVet-Americas new Adipose-Derived Stem Cell Procedure Kit, veterinary practitioners in 200 markets throughout 42 states now perform the drug-free procedure entirely in their own clinics more quickly, effectively and economically than first generation animal stem cell therapy. This new treatment, developed in Australia, is now available in 23 countries worldwide.
The stem cell advancements in veterinary medicine are paving the way for healthier and happier lives for pets in America.
Some areas of research and therapy are progressing faster than that in human medicine, said MediVet-America managing director Jeremy Delk. Stem cell therapy is at the leading edge of this evolution.
Stem cells are basic biological cells which have the ability to differentiate into specialized tissue cells and regenerate to additional cells. These new cells can be beneficial in replacing or repairing damaged tissue. The stem cells used in veterinary medicine arent embryonic, the type which have garnered much controversy over the years, but are taken from adipose (fat) tissue of the individual patient.
MediVet, the worlds leading animal stem cell company, is offering the newest and most advanced stem cell techniques that are changing the landscape of veterinary medicine. The regenerative cells are injected into the pets joints to encourage connective tissue like cartilage, tendons and ligaments to heal or grow including other degenerative diseases.
Delk said that trials, thousands of procedures and studies have shown significant improvement in quality of life for dogs, cats, and horses even Cinnamon the goat, camels and other wild animals with arthritis and other joint diseases.
More than 3,000 stem cell kits have been supplied to veterinarians across the U.S., who are seeing tremendous results. Animals that had been unable to climb stairs or walk well, are running and playing.
We have experienced tremendous growth this year in all areas of our business, said Delk. Were overwhelmed by the enthusiastic response weve received from pet owners and veterinarians around the world, and were deeply honored by the pet industrys acknowledgement of our services.
Excitement in the technology continues to grow as we are now seeing stem cell procedures happening everyday across the United States and the world.
Americans spent $ 48.3 billion in 2010 on their companion animals, according to the American Pet Products Association, up from $ 28.5 billion in 2001. The cost of a stem cell treatment is about $ 1,900 for small animals, $ 2,400 for horses. Stem cells also can be frozen and banked.
MediVet is seeking distributors in America and other parts of the world to serve its growing number of veterinarians and clinics.
We feel that it is an excellent opportunity for entrepreneurs who are interested in entering the expanding bio-medical field in a unique way, said Delk.
Delk said veterinarians can become in-house stem cell therapy clinics allowing them to perform procedures in real time for the small cost of necessary equipment of just $ 7,000.
IN THE NEWS: http://www.whas11.com/news/Stem-cell-therapy-breakthrough-benefits-goat-could-benefit-other-animals-130368428.html.
A research and development company and global leader in veterinary stem cell technology, MediVet-America provides innovative cell applications for the therapeutic care of animals. Headquartered in Nicholasville, Kentucky, MediVet-America develops advanced cellular designed kits and services for the treatment of osteoarthritis and degenerative joint disease. The company also offers MediVet Lab Services in multiple locations around the world that provides technical support for in-house stem cell vets, as well as regional and national Adipose stem cell processing and cyro banking services for pets at a young age or for a maintenance program, autologous conditioned serum processing, and cell counting for in-house stem cell procedures. Information on animal stem cell treatment and banking services are available at http://www.MediVet-America.com.
# # #
Find More Osteoarthritis Arthritis Press Releases
Question by reendave: Does anyone have rheumatoid arthritis in their feet? What were your first symptoms? How do u know?
My feet have been hurting for quite some time and ache and burn. I can walk on them but it is very painful. Even at rest they ache and burn. I have noticed the joint closest to my foot on my second toe is swollen and it hurts to curl my toes. It is also painful for them to be touched or rubbed. This has been going on for several months now. I wear tennis shoes and I can only wear this old pair as anything else hurts my feet severly..so much that I really can not walk for a day or two. I have always been one that hates to wear shoes, but now I can not stand to be without shoes as when I am barefoot I feel like my feet are splitting in two.
Answer by Georgia
The most common symptoms of RA in the foot are pain, swelling, and stiffness. Symptoms usually appear in several joints on both feet. You may feel pain in the joint or in the sole or ball of your foot. The joint may be warm and the way you walk may be affected.
Mine started off with feeling like the joints of my toes needed to crack, like the knuckles in your hand.
Try wearing Crocs. The shape of the shoe is helpful and doesn’t press on your toes like other shoes do. You can also try to get moccasin type shoes. Visit a shoestore that sells wide widths, so that with socks you don’t have anything pressing on your feet.
Give your answer to this question below!
This is my first Enbrel injection I gave myself at home. I had my first shot at the doctor’s office 3 days ago. I was a little nervous this time. I haven’t seen any improvement on my psoriasis yet but I wasn’t expecting to this early. I have, however, been able to bend my toes now which is a HUGE improvement!! Sorry about the crotch shot! LOL the bandaid tried to hide. Anyway, follow my blog at perfectlyimperfectkatie.blogspot.com for more information! Thanks for your support!
(Submission for the National Psoriasis Foundation’s Psoriasis Awareness Month Spotlight on Psoriasis and Psoriatic Arthritis Online Film Festival 2011. Learn more at www.psoriasis.org/pam)
Sacramento, CA (PRWEB) May 18, 2012
Monday, attorneys at Kershaw, Cutter & Ratinoff initiated an early trial date for a lawsuit* involving the DePuy ASR hip replacement recall. It will likely be one of the first of more than 7,000 DePuy ASR cases in the country to be tried before a jury.
KCR’s lawyers report that they are seeking an expedited trial date on behalf of a client who alleges she is currently suffering from an incurable staph infection she acquired during a surgery to remove her recalled DePuy ASR hip.* Under California law, anyone over the age of 70 who is suffering from a life threatening health condition may obtain an expedited trial date.
First Aid Only Products – First Aid Only – Cold Compress, 4 x 5 – Sold As 1 Each – Instant cold compress temporarily relieves minor pain and swelling for sprains and sore joints. – No pre-chilling required. – Reviews
First Aid Only Products – First Aid Only – Cold Compress, 4 x 5 – Sold As 1 Each – Instant cold compress temporarily relieves minor pain and swelling for sprains and sore joints. – No pre-chilling required. -
- Instant cold compress temporarily relieves minor pain and swelling for sprains and sore joints.
- No pre-chilling required.
First Aid Only – Cold Compress, 4 x 5 – Sold As 1 Each
Instant cold compress temporarily relieves minor pain and swelling for sprains and sore joints. No pre-chilling required. Width: 4 in; Depth: 5 in; Number of Pieces: 1; For Use With: N/A.
Instant cold compress temporarily relieves minor pain and swelling for sprains and sore joints.No pre-chilling required.
Includes one cold compress.
List Price: $ 8.05
Price: $ 5.87
San Francisco, CA (PRWEB) April 4, 2011
Jeffrey Gottfurcht may have only one climb left. Buoyed by a personal quest and the goal of inspiring others, the 38-year-old founder of The Jeffrey Gottfurcht Childrens Arthritis Foundation (JGCAF) and former finance executive, plans to be the first patient with rheumatoid arthritis to climb Mount Everest at 29,035 feet.
Gottfurcht, who lives in the San Francisco area, will begin his journey to the world’s highest mountain accompanied by a guide and a Sherpa on what is typically an eight week climb, subject to favorable weather conditions.
Gottfurcht would be the first climber with rheumatoid arthritis to scale Everest. He has been climbing mountains since his teens; at 28 he was diagnosed with this autoimmune disease, which attacks the joints and causes inflammation, joint pain and stiffness, while leading to fatigue and permanent joint damage. Without treatment, patients with rheumatoid arthritis (RA) may suffer deformity, disability and diminished quality of life and would certainly not feel up to the grueling task of climbing Mount Everest.
“In coping with rheumatoid arthritis, an incurable disease, I have been moved to reach out to others who are similarly affected, especially children, who have to put everything on hold, including their dreams. My goal of climbing Mount Everest is to inspire those with rheumatoid arthritis, whether adults or children, to reach higher and achieve their dreams,” Gottfurcht said.
Amazingly, even after his RA diagnosis, Gottfurcht conquered other peaks, including Mt. Elbrus (Russia, 18,500 feet), Mt. Rainier (Washington, 14,400 feet) and Pico de Orizaba (Mexico, 18,400 feet). Due to severe joint pain and immobility, Gottfurcht had not been able to climb for the first two years following his diagnosis but vowed that he would one day climb again … and he did. His determination and will to climb again were in direct response to the original diagnosis. His was an aggressive form of the disease, which most likely would render him functionally immobile within ten years. A prognosis he simply refused to accept.
A key supporter of Gottfurcht’s climb is Rik J. Deitsch, Chairman and CEO of Nutra Pharma Corporation (OTCBB: NPHC), a biotechnology company that is developing treatments for Multiple Sclerosis (MS), Human Immunodeficiency Virus (HIV), Adrenomyeloneuropathy (AMN) and pain. Gottfurcht uses the company’s medication Nyloxin, an over-the-counter treatment for chronic pain, to aid in relieving the pain and inflammation that accompanies rheumatoid arthritis. According to Deitsch, “As a sponsor of Jeffrey on his historic Everest climb, we want people to become aware of rheumatoid arthritis and Jeffreys Foundation. We want all chronic pain sufferers — and medical professionals — to understand that, if Nyloxin can be effective in this extreme use and in this extreme activity, imagine how effective it will be to manage the everyday pain and inflammation of rheumatoid arthritis.
Gottfurcht, the father of three young children, created the JGCAF, a wish-granting organization that grants dreams ranging from requests to help cover educational and medical costs to requests for big screen computers or Wii systems to help a child affected by arthritis to cope with limited visibility or mobility. Some dream requests are from juvenile arthritis patients seeking a moment to connect with a revered sports or pop culture icon to help them endure the intense pain of everyday life and medical treatment.
Children age 4 to 21 afflicted with juvenile arthritis are eligible for a wish grant. The Foundation encourages a member of a childs medical team (doctor, nurse, social worker or child-life specialist), a parent, sibling or legal guardian to propose a wish for a child suffering from juvenile arthritis. Children with juvenile arthritis may send in their dream request directly. After JGCAF receives the dream request, the Foundation contacts the childs treating physician to determine if the child is medically eligible for the requested wishand then works with its network of supporters to make the wish come true.
The Jeffrey Gottfurcht Childrens Arthritis Foundation was founded by Jeffrey Gottfurcht as a way to inspire, educate and generate awareness of both rheumatoid and juvenile idiopathic arthritis, as those suffering optimistically await a cure. In 2002, at the age of 28, Gottfurcht was diagnosed with RA and after undergoing years of treatment; he wanted to share his determination to fight the disease while bringing joy, strength and support to children and young adults similarly afflicted. A wish-granting Foundation, JGCAF accepts referrals for dreams from parents, guardians, siblings, members of the medical community, and directly from children suffering from juvenile rheumatoid arthritis. The Foundations Dream Team helps select dreams that are prudent and possible and assists in making them come true. Help us fulfill a dream of a child living with Juvenile Arthritis today. For more information or to make donations please call 310.855.3745 or visit http://www.JGCAF.org.
About Nutra Pharma Corp.
Nutra Pharma Corporation operates as a biotechnology company specializing in the acquisition, licensing, and commercialization of pharmaceutical products and technologies for the management of neurological disorders, cancer, autoimmune, and infectious diseases, including Adrenomyeloneuropathy (AMN), Multiple Sclerosis (MS), and Human Immunodeficiency Virus (HIV). Additionally, the Company markets several drug products for sale for the treatment of pain under the brands Cobroxin and Nyloxin. For additional information about Nutra Pharma, visit http://www.NutraPharma.com.
Note: To respect the privacy of its dream recipients, the JGCAF does not disclose their full names.
# # #
Parker Waichman LLP Reports Progress in DePuy ASR Hip Replacement Implant Lawsuits, First Trials May Start this Year in Federal Metal-on-Metal Hip Replacement Litigation
New York, New York (PRWEB) May 02, 2012
Parker Waichman LLP, a national law firm dedicated to protecting the legal rights of people injured by metal-on-metal hip replacement implants and other defective medical devices, reports that bellwether trials could commence later this year in the DePuy Orthopaedics, Inc. ASR Hip Implant Products Liability Litigation currently underway in U.S. District Court, Northern District of Ohio (MDL No. 2197). According to Parker Waichman LLP, bellwether trials are used when a large group of plaintiffs have filed suit based on the same theory or claim. Verdicts in these key trials will help gauge how juries might rule in thousands of similar DePuy ASR hip replacement lawsuits pending in the litigation.
According to a report from Bloomberg News, DePuy and Johnson & Johnson have been named in more than 4,200 lawsuits in the federal MDL, while another 2,000 cases are pending in state courts throughout the country. During an MDL status conference held yesterday in Florida, attorneys representing both plaintiffs and defendants told U.S. District Judge David Katz that they had agreed that bellwether trials should be scheduled. [bloomberg.com/news/2012-05-01/j-j-hip-patients-will-take-bellwether-cases-to-trial-1-.html]
Parker Waichman LLP is representing numerous plaintiffs in the DePuy ASR hip implant MDL. Lawsuits pending in the litigation allege that minute particles of chromium and cobalt shed from the metal-on-metal hip implants can cause a variety of health problems, including tissue death, dangerous levels of metal ions in the bloodstream, pain, infection and the need for revision surgery, according to the firm.
DePuy Orthopaedics issued a global recall of the ASR Hip Resurfacing System and ASR Acetabular System in August 2010, after data from the National Joint Registry of England and Wales showed that 1 out of every 8 patients (12%-13%) who had received the devices had to undergo revision surgery within five years of receiving it. According to Parker Waichman LLP, more than 93,000 metal-on-metal DePuy ASR hip implants were sold worldwide prior to their recall. [depuy.com/asr-hip-replacement-recall]
The U.S. Food & Drug Administration (FDA) is currently conducting a safety review of metal-on-metal hip implants, including the DePuy ASR devices. Last May, the agency directed 21 companies that market all-metal hip replacements, including DePuy, to conduct post-market studies of their products to determine if they were shedding dangerous amounts of metallic debris in patients. The FDA recently announced that its Orthopaedic and Rehabilitation Devices Panel will meet on June 27 and 28 to discuss the risks and benefits of metal-on-metal hip systems, and make potential patient and practitioner recommendations for their use. – http://www.fda.gov/MedicalDevices/ProductsandMedicalProcedures/ImplantsandProsthetics/MetalonMetalHipImplants/ucm241604.htm
In March, a group of researchers writing in The Lancet called on doctors to stop using metal-on-metal hip implants after a study they conducted found that there is a 6.2 percent chance that patients with such devices will need a replacement within just five years. The month prior, a report in the British Medical Journal warned that hundreds of thousands of people around the world may have been exposed to dangerously high levels of toxic and potentially cancer-causing metals from failing metal-on-metal hip implants. [helancet.com/journals/lancet/article/PIIS0140-6736%2812%2960353-5/fulltext; bmj.com/content/344/bmj.e1410]
Parker Waichman LLP continues to offer free legal consultations to victims of DePuy ASR hip implant injuries. If you or a loved one experienced premature failure of your implant or other health problems associated with a recalled DePuy ASR Hip Implant, please contact their office by visiting the firm’s DePuy ASR hip implant injury page at http://www.yourlawyer.com. Free case evaluations are also available by calling 1 800 LAW INFO (1-800-529-4636).
For more information regarding defective hip implant lawsuits and Parker Waichman LLP, please visit: http://www.yourlawyer.com or call 1-800-LAW-INFO (1-800-529-4636).
Parker Waichman LLP
Gary Falkowitz, Managing Attorney
Phillies Stars (Hamels, Utley, Rollins, and Victorino) Join Leading Financial Institutions for Charity in First Annual Philly Financial Day
Philadelphia, PA (PRWEB) May 31, 2011
Cole and Heidi Hamels, co-founders of The Hamels Foundation, are pleased to announce plans for the first annual Philly Financial Day on Friday, July 8th, 2011. Several of the leading financial service institutions in the Philadelphia area will donate a significant fixed percentage of their institutional trading commissions and transactional revenues to a pool of charitable foundations founded by Phillies stars Cole Hamels, Shane Victorino, Jimmy Rollins and Chase Utley. In addition, The Childrens Hospital of Philadelphia (CHOP) will be a beneficiary of funds raised that day.
The day represents a great opportunity for the Philadelphia investment community and the Phillies players to translate their already collective synergy into something tangible for a host of tremendous charities, commented Cole Hamels. Not only is this a great opportunity to raise significant funds, it is also a day for the city to celebrate our long financial history and shine a light on all the positive things happening here in that industry space. Were excited that the rest of the country will get a chance to experience a bit of Philadelphia on this day through the coverage.
Janney Montgomery Scott LLC and Boenning & Scattergood, Inc. have graciously volunteered to be the core transaction execution venues on July 8th. We are very fortunate and grateful that these institutions have agreed to donate a significant part of that days revenue to our very worthy causes, said Shane Victorino, founder of The Shane Victorino Foundation.
In the month leading up to the event, members of the various foundations will meet with a number of leading mutual funds, hedge funds and money management firms. They will ask them to direct as much of their institutional equity/fixed income/derivative commissions and transactions to these execution venues on July 8th, thus contributing as much as they can to the total amount that will be given to the charities.
To help raise visibility, NASDAQ OMX PHLX (formerly the Philadelphia Stock Exchange) will host the Phillies players during their visit to New York at the NASDAQ MarketSite in Times Square on Friday, May 27th, 2011. The NASDAQ MarketSite seven-story LED Tower will broadcast the foundation logos and the players will conduct media interviews at the street-level television studio for fans in Times Square to view. PHLX will host part of the 1st annual Philly Financial Day on Friday, July 8th from their trading floor in Philadelphia, which represents the oldest and largest equity options exchange in the United States.
We look forward to getting a chance to experience the excitement and energy on the trading desks at Janney and Boenning and to be on the exchange floor in person as well. Also, with local and national media coverage concentrated on Philadelphia that day, we think it will be a home run for everyone involved, especially CHOP and the other charities which will ultimately benefit noted Jimmy Rollins of The Jimmy Rollins Family Foundation.
We know there are a lot of 401(k) and mutual fund institutions in the greater Philadelphia area doing business with Phillies fans and Philadelphia businesses and we urge them to be a part of Philly Financial Day to support us and our communities, commented Chase Utley, co-founder of The Utley Foundation.
There will be two opportunities for press with participating Phillies players:
Media Press Conference- Friday, May 27th 9:30am EST at the NASDAQ MarketSite in New York Citys Times Square
4 Times Square
43rd & Broadway
New York, NY 10036
Robert Madden, NASDAQ Corporate Communications
G-N Kang, The Hamels Foundation Director of Operations
Official Press Tour- Friday, July 8th 8:30am-11:15am EST in Philadelphia, PA
All participating financial institutions
For more details, please contact:
G-N Kang, The Hamels Foundation Director of Operations
About The Hamels Foundation
Beginning in 2008, The Hamels Foundation has been dedicated to bringing an end to extreme poverty and hardship endured by lack of educational support.
Co-founded by Cole and Heidi Hamels, The Hamels Foundation has a dual mission to provide support for quality education in the United States and establish a school in Malawi, Africa.
The Hamels Foundation takes a community-based approach to education by providing assistance to inner-city schools as well as supporting other education based non-profit entities in the United States. This includes, but is not limited to, providing stimulating learning environments, high-quality educational programs and necessary provisions to promote learning. The Hamels Foundation currently gives the largest public school grants in Philadelphia. For example, in 2010, Wilson Elementary received a $ 50,000 grant to build a schoolyard playground.
The commitment of The Hamels Foundation extends globally to Malawi, Africa where there are over one million orphans due to the HIV/AID pandemic. Malawi is one of the poorest, most impoverished nations in the world. The Hamels Foundation is dedicated to building a boarding school that will educate nearly 2,000 boys and girls in the Mulanje District of Malawi. The first step towards breaking the cycle of AIDS is education, as well as tending to basic needs such as shelter and food. The foundations goal is to provide this first step in improving the lives of thousands. In 2010, $ 40,000 was donated to Global AIDS Interfaith Alliance (GAIA) to build a new well for safe drinking water and to put over 1,200 children through school for an entire year.
About The Shane Victorino Foundation
Shane and Melissa Victorino founded the Shane Victorino Foundation (SVF) in 2010. The nonprofit is dedicated to promoting opportunities for underserved youth in Philadelphia and Hawaii as it engages in projects which provide children with educational, recreational and wellness programs. The organizations first major endeavor in Philadelphia was to pledge nearly $ 1 million to renovate the 105-year old Nicetown Boys & Girls Club, which will reopen at the end of the summer. Additionally, the SVF currently sponsors the Flyin Hawaiian All-Stars charity ticket program which provides childrens groups with game tickets, t-shirts and concessions. In Shanes native Hawaii, the Foundation supports projects serving disadvantaged children. Over the past three years alone, the SVF has raised more than a half-of-a-million dollars for various charities, including the Hawaii Childrens Cancer Foundation, Boys & Girls Clubs of Maui and others.
About The Jimmy Rollins Foundation
The Jimmy Rollins Foundation strives to help children and young adults living with arthritis by providing funds and awareness about the disease. They also support families who are struggling financially with extracurricular activities that promote healthy living through exercise and proper nutrition. Rollins and the Foundation host an annual charity bowling tournament at Lucky Strikes Lanes in Philadelphia that features teammates, celebrities and musicians.
This event benefits the Eastern Pennsylvania Juvenile Arthritis Foundation and the Rollins Family Foundation. Last years event raised over $ 174,000 for both foundations. In 2007, Rollins developed JRolls Aces to reward children in disadvantaged areas who excelled in the classroom. Under this program, Rollins meets with groups on the field during batting practice to answer questions, sign autographs, and provide each participant with a game ticket, t-shirt and food vouc